- Home
- MBRX vs UPC Comparison
MBRX vs UPC Comparison
Compare MBRX & UPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBRX
- UPC
- Stock Information
- Founded
- MBRX 2015
- UPC 1998
- Country
- MBRX United States
- UPC China
- Employees
- MBRX N/A
- UPC 225
- Industry
- MBRX Biotechnology: Pharmaceutical Preparations
- UPC Biotechnology: Pharmaceutical Preparations
- Sector
- MBRX Health Care
- UPC Health Care
- Exchange
- MBRX Nasdaq
- UPC Nasdaq
- Market Cap
- MBRX 1.4M
- UPC 1.5M
- IPO Year
- MBRX 2016
- UPC 2021
- Fundamental
- Price
- MBRX $1.28
- UPC $0.20
- Analyst Decision
- MBRX Strong Buy
- UPC
- Analyst Count
- MBRX 2
- UPC 0
- Target Price
- MBRX $24.00
- UPC N/A
- AVG Volume (30 Days)
- MBRX 13.3M
- UPC 803.8K
- Earning Date
- MBRX 03-21-2025
- UPC 01-01-0001
- Dividend Yield
- MBRX N/A
- UPC N/A
- EPS Growth
- MBRX N/A
- UPC N/A
- EPS
- MBRX N/A
- UPC N/A
- Revenue
- MBRX N/A
- UPC $26,725,919.00
- Revenue This Year
- MBRX N/A
- UPC N/A
- Revenue Next Year
- MBRX N/A
- UPC N/A
- P/E Ratio
- MBRX N/A
- UPC N/A
- Revenue Growth
- MBRX N/A
- UPC N/A
- 52 Week Low
- MBRX $0.40
- UPC $0.12
- 52 Week High
- MBRX $6.24
- UPC $4.32
- Technical
- Relative Strength Index (RSI)
- MBRX 46.92
- UPC 33.30
- Support Level
- MBRX $1.55
- UPC $0.16
- Resistance Level
- MBRX $2.22
- UPC $0.21
- Average True Range (ATR)
- MBRX 0.50
- UPC 0.04
- MACD
- MBRX 0.08
- UPC 0.03
- Stochastic Oscillator
- MBRX 27.12
- UPC 20.13
About MBRX Moleculin Biotech Inc.
Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.
About UPC Universe Pharmaceuticals Inc.
Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.